Loading
Latest filing published 13 May 2024 for IGC Pharma, Inc., €2.8M.
No signal scores available.
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) has a single filing on record, published on 13 May 2024: a share grant of €2.8M in IGC Pharma, Inc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration